Skip to main content
MICROSAIC SYSTEMS PLC logo

MICROSAIC SYSTEMS PLC — Investor Relations & Filings

Ticker · MSYS ISIN · GB00BMWC8365 LEI · 213800P1VXZSD3US5N79 IL Manufacturing
Open in API
Filings indexed 368 across all filing types
Latest filing 2019-03-05 Regulatory Filings
Country GB United Kingdom
Listing IL MSYS

About MICROSAIC SYSTEMS PLC

https://www.microsaic.com/

Microsaic Systems PLC is a high-technology company that develops, manufactures, and supplies micro-electronic analytical instrumentation. The company specializes in miniaturized, real-time, point-of-need mass spectrometers based on patented chip-based technology. These instruments are designed to improve the efficiency of chemical and biological workflows by enabling rapid analytical detection and characterization. While its technology serves industries such as biopharma, pharmaceuticals, and food and beverage, the company is also focused on providing analytical solutions for environmental monitoring, particularly for detecting toxins and pathogens in water.

Recent filings

Filing Released Lang Actions
MSYS jointly publishes bioprocessing data with MIT
Regulatory Filings Classification · 98% confidence The document is a press release distributed via the London Stock Exchange's RNS (Regulatory News Service). It announces a joint publication between Microsaic Systems plc and MIT regarding bioprocessing data. Since this is a general corporate announcement regarding business operations and research collaboration that does not fit into specific categories like financial results, dividends, or board changes, it is classified as a general regulatory filing.
2019-03-05 English
Investor Event
Report Publication Announcement Classification · 99% confidence The document is a short announcement (2923 characters) issued via RNS (RNS Number : 8042R) on March 5, 2019. It states that Microsaic Systems plc 'announces that it will be hosting an investor event on 11 March 2019' which will include a presentation discussing the 'annual results'. Since the document is an announcement about an upcoming event where reports/results will be discussed, and it is not the report itself, it fits the criteria for a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given that it specifically announces the publication/discussion of results at an event, RPA is a strong candidate, but RNS is the general regulatory announcement category. Since the primary purpose is to inform the market about an upcoming event/presentation, and it is short, RPA (Report Publication Announcement) is the most specific fit if the event is considered the 'publication' mechanism for the results discussion. However, since it is a general announcement of an event, RNS (Regulatory Filings) is also highly applicable as a fallback for non-standard announcements. Given the content is an announcement of an investor event, RPA is slightly more specific than the general RNS category, as it relates to the communication of company performance information.
2019-03-05 English
Notice of Results
Report Publication Announcement Classification · 99% confidence The document is very short (2429 characters) and its primary purpose is to announce *when* the final results will be reported ('Microsaic Systems plc... announces that the Company will be reporting final results for the 12 months ended 31 December 2018 on Monday 11 March 2019'). It is not the results themselves, nor is it a comprehensive report like a 10-K or IR. It is an announcement about the publication of a future report. The presence of 'RNS Number' and the closing statement referencing 'RNS, the news service of the London Stock Exchange' strongly suggests this is a regulatory news service announcement. According to Rule 2, when a document announces the publication of a report rather than containing the full report, it should be classified as a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Since RPA specifically covers announcements regarding the timing/release of reports, it is the most precise fit.
2019-02-19 English
New Protein Identification Product
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated 11 January 2019. It announces a new product ('Microsaic announces new protein identification product') and provides details about its features and market relevance. The text concludes with contact information and a standard disclaimer stating, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This structure is characteristic of a general regulatory news service announcement, which falls under the 'Regulatory Filings' category (RNS) as it is not a specific financial report (like 10-K, IR, ER) or a specific corporate action (like DIV, DIRS, CAP). Given the content is a product announcement disseminated via the RNS system, RNS is the most appropriate classification.
2019-01-11 English
Bioprocessing partnership update & trading update
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated 19 December 2018. It contains language typical of a regulatory announcement, such as 'THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014.' It provides an update on a partnership and trading, which is a form of business update, but the key identifier is the RNS header and the closing statement referencing RNS as the news service of the London Stock Exchange. Since this is a general regulatory announcement that doesn't fit the specific categories like ER (Earnings Release), IR (Interim Report), or DIRS (Director's Dealing), the most appropriate classification is the general regulatory filing category, RNS.
2018-12-19 English
Exclusive US and Canada Distribution Agreement
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and is dated 07 November 2018. It announces a significant business event: signing an 'Exclusive US and Canada Distribution Agreement'. This type of announcement, which details a commercial partnership or operational update and is disseminated via the Regulatory News Service (RNS), typically falls under general regulatory announcements if it doesn't fit a more specific category like M&A (TAR) or Capital Change (CAP). Since it is a general business update distributed through the RNS system and doesn't fit the definitions for ER, IR, 10-K, or any other specific financial report type, the most appropriate classification is the general regulatory filing category.
2018-11-07 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.